首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >Systematic Review With Meta‐Analysis of Patient‐Centered Outcomes, Comparing International Guideline–Recommended Enteral Protein Delivery With Usual Care
【24h】

Systematic Review With Meta‐Analysis of Patient‐Centered Outcomes, Comparing International Guideline–Recommended Enteral Protein Delivery With Usual Care

机译:系统审查与患者以患者为中心的结果,比较国际指南 - 推荐的肠内蛋白质递送常规护理

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background International guidelines recommend that protein be administered enterally to critically ill patients at doses between 1.2 and 2 g/kg per day Observational data indicate that patients frequently receive less protein. The aim of this systematic review was to evaluate patient‐centered outcomes with guideline‐recommended enteral protein compared with usual care. Methods A systematic review was performed of randomized controlled trials including critically ill adult patients provided predominately enteral nutrition with mean protein at ≥1.2 g/kg per day (intervention) and 1.2 g/kg per day (comparator). Random‐effects models were applied for outcomes reported in ≥3 trials. Results Of 1375 abstracts, 69 full‐text articles were reviewed, and 6 trials meet the inclusion criteria, including 511 patients. The intervention group received a mean (SD) of 1.3 (0.08) g/kg per day, and the comparator group received 0.75 (0.15) g/kg per day protein. Insufficient data were available for meta‐analyses on the primary outcome (muscle mass or strength). According to our meta‐analyses, mortality at 28 days (5 studies) (risk ratio 0.92 [95% Cl 0.63–1.35], P = .66) and the durations of intensive care unit (6 studies) and hospital admission (4 studies) were similar between the intervention and comparator, with some uncertainty due to sample sizes and heterogeneity. Conclusion There are insufficient data to conclude whether protein provision within the current international guideline recommendations improves outcomes. In a limited dataset, enteral protein intakes near the lower level of current recommendations do not appear to reduce admission duration or mortality when compared with usual care in critically ill.
机译:摘要背景国际指南建议蛋白质在每天1.2和2g / kg的剂量下肠道给予危重患者,观察数据表明患者经常接受较少的蛋白质。该系统审查的目的是评估与通常护理的指导推荐肠内蛋白质的患者为中心的结果。方法对随机对照试验进行系统评审,包括批评性的成年患者,其主要肠内患者提供肠内营养,平均蛋白质每天≥1.2g/ kg(干预),每天≥1.2g/ kg(比较器)。随机效应模型用于≥3试验报告的结果。结果1375年摘要,69条全文文章进行了审查,6项试验符合纳入标准,包括511名患者。干预组接受每天1.3(0.08)克/千克的平均值(SD),对比较器基团得到0.75(0.15)克/千克/千克蛋白。对主要结果(肌肉质量或强度)的Meta-Analys的数据不足。根据我们的荟萃分析,28天(5项研究)的死亡率(风险比0.92 [95%CL 0.63-1.35],P = .66)和重症监护单位(6项研究)和医院入院的持续时间(4研究)在干预和比较器之间类似,由于样本尺寸和异质性,具有一些不确定性。结论数据不足以结束当前国际指南建议内的蛋白质是否有所提高结果。在有限的数据集中,肠内蛋白在当前建议的较低水平附近的摄入量似乎在与通常的护理中相比,在危险不良的情况下,似乎不会降低入院持续时间或死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号